home FAQ email sign-up search contact us
Headlines Email Alert Sign-up
HealthCast Calendar
Daily Reports Health Poll Search
Issue Spotlight
<a href="http://www.kaisernetwork.org/daily_reports/rep_index.cfm"><img src="http://www.kaisernetwork.org/images/index_flash_headlines.gif" width="437" height="42" border=0></a>
HealthCast
How to View
Calendar
Editorial Policies
Email Alert Sign-Up
Search the HealthCast Archives
 

Site Search

 


Today's Topics In Health Disparities - Race and Genetics: The Future of Personalized Medicine 8/20/2008
Kaiser Family Foundation Broadcast Studio - Washington, D.C.

 
 
  • Add to My Saved Links
  • Email this Webcast
  • RSS Feeds
  • Podcast Feeds
 
 
Support Files

Race-Based Therapeutics   (.pdf)
  
By: Clyde W. Yancy
Current Hypertension Reports 2008 Aug, 1 (4):276–285
Philadelphia: Current Medicine Group, LLC

 

Additional Resources

Publications and Reports

Key Facts: Race, Ethnicity and Medical Care, 2007 Update

Key Health Disparities-Focused Legislation Introduced in the 110th Congress

Kaiser Family Foundation: Health Coverage and Access to Care Among Asian Americans, Native Hawaiians and Pacific Islanders

Key Health and Health Care Indicators by Race/Ethnicity and State

Kaiser Family Foundation: Minority Health

Kaiser Health Disparities Report: A Weekly Look at Race, Ethnicity and Health

StateHealthFacts.org - Minority Health

Today's Topics In Health Disparities

View a webcast of the Kaiser Family Foundation's series, Today’s Topics In Health Disparities, which discusses the potential of race-based medical solutions for improving healthcare and reducing racial/ethnic health disparities. The webcast takes a closer look at efforts to study the interaction between race, genetics and health.

 

Panelists discuss the efforts underway to develop medications to treat diseases that disproportionately affect certain racial and ethnic groups, as well as the benefits and drawbacks of using genetic markers for race in medical decisions. Other topics covered include which genetic factors are being used to personalize medicine and what pharmaceutical companies are doing to target the drugs and treatments they offer to certain groups.


Full version:

Video
Podcast
Transcript
Speakers for this session:

 
Marsha Lillie-Blanton, Dr.P.H.

Senior Advisor on Race, Ethnicity and Health Care

Kaiser Family Foundation

Moderator

Bio
 
 
Clyde Yancy, M.D., FACC, FAHA, FACP

Medical Director, Baylor Heart and Vascular Institute

Chief, Cardiothoracic Transplantation, Baylor University Medical Center

Bio
 
 
Dorothy Roberts, J.D.

Kirkland & Ellis Professor

Northwestern University Law School  

Bio
 
 
Richard Levy, Ph.D.

President, Levy Consulting

Former Vice-President for Scientific Affairs, National Pharmaceutical Council

Bio



EMAIL ALERTS
Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news and events.
 
FAQs
More...
 
CONTACT US
Contact us by email with any comments, problems, suggestions.
Call the kaisernetwork.org Help Desk at 202-347-5270.
...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ......


About Us     Privacy Policy      Help      Site Map